ExLibris header image
SFX Logo
Title: p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells
Source:

Nature Medicine [1078-8956] Ihry, Robert yr:2018


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. "Frequent loss of heterozygosity in CRISPR-Cas9–edited early human embryos." Proceedings of the National academy of sciences of the United States of America 118.22: 1-. Link to SFX for this item
2. Enache, Oana M. "Cas9 activates the p53 pathway and selects for p53-inactivating mutations." Nature Genetics 52.7 (2020): 662-668. Link to SFX for this item
3. "Protein tyrosine phosphatase 1B regulates endothelial endoplasmic reticulum stress; role in endothelial dysfunction." Vascular pharmacology. . Link to SFX for this item
4. "Clustered Regularly Interspaced Short Palindromic Repeats Genotyping of Multidrug-Resistant Salmonella Heidelberg Strains Isolated From the Poultry Production Chain Across Brazil." Frontiers in microbiology. 13: 867278-867278. Link to SFX for this item
5. Modarai, Shirin R. "Precise and error-prone CRISPR-directed gene editing activity in human CD34+ cells varies widely among patient samples." Gene therapy. 28.1-2: 105-113. Link to SFX for this item
6. Frangoul H, H. "CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia." The New England journal of medicine. 384.3: 252-260. Link to SFX for this item
7. "CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. Reply." The New England journal of medicine. 384.23. Link to SFX for this item
8. "CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia." New England journal of medicine 384.23. Link to SFX for this item
9. "CRISPR/Cas9 gene editing for curing sickle cell disease." Transfusion and apheresis science 60.1: 103060-103060. Link to SFX for this item
10. Esrick, Erica B. "Post-Transcriptional Genetic Silencing of BCL11A to Treat Sickle Cell Disease." The New England Journal of Medicine 384.3 (2021): 205-215. Link to SFX for this item
11. Haapaniemi, E. "CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response." Nature Medicine 24.7 (2018): 927-930. Link to SFX for this item
12. "CRISPR/Cas9 therapeutics: progress and prospects." Signal transduction and targeted therapy. 8.1: 36-36. Link to SFX for this item
13. "China tightens rules on gene editing: Move is response to CRISPR-altered babies." Science. 363.6431: 1023-. Link to SFX for this item
14. Bak, Rasmus O. "CRISPR/Cas9 genome editing in human hematopoietic stem cells." Nature Protocols 13.2 (2018): 358-376. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.